Abstract
Comorbidities are chronic conditions that co-exist with a primary diagnosis of interest. It is often understood that many patients with advanced heart failure frequently have more than one major chronic comorbid condition which are often associated with increased health utilization and increased mortality (Iorio et al., Eur J Heart Fail 20:1257–66, 2018; Koen et al., Int J Cardiol 271:132–9, 2018). Comorbidities are not necessarily a contraindication to LVAD therapy; however, they may impact the postoperative recovery phase, including mobility and wound healing. Prior to LVAD implant, patients must have all major comorbid conditions optimized for successful outcome. This includes but not limited to ensuring optimal end-organ function, glycemic control, elimination of infection, and mental readiness of both patient and caregiver. This chapter provides guidelines and considerations for optimization before LVAD implantation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Change history
11 January 2023
Chapter 16 in: Stewart, S., Blood, P. (eds) A Guide to Mechanical Circulatory Support. Springer, Cham. https://doi.org/10.1007/978-3-031-05713-7_16
References
Peura JL, et al. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation (New York, N.Y.). 2012;126(22):2648–67.
The Society of Thoracic Surgeons. Intermacs database [Online]. 2021. https://www.sts.org/registries-research-center/sts-national-database/intermacs-database.
Alba AC, et al. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant. 2009;28(8):827–33.
Adult-gerontology acute care nurse practitioner certification review. Los Angeles, CA: Barkley & Associates, Inc.; 2021.
Nassif ME, Patel JS, Shuster JE, Raymer DS, Jackups R Jr, Novak E, Gage BF, Prasad S, Silvestry SC, Ewald GA, LaRue SJ. Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device. JACC Heart Fail. 2015;3(2):146–53. https://doi.org/10.1016/j.jchf.2014.08.005.
Fried J, et al. Prior hematologic conditions carry high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2014;33(11):1119–25.
Hillebrand J, et al. Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia. J Artif Organs. 2015;18(4):291–9.
Paul S, et al. Heart failure nursing certification: core curriculum review. 2nd ed. Mount Laurel, NJ: American Association of Heart Failure Nurses; 2018.
Okoh AK, Selevany M, Heaton J, Al-Obaidi N, Vucicevic D, et al. Outcomes of obese patients bridged to heart transplantation with a left ventricular assist device. ASAIO J. 2021;67(2):137–43. https://doi.org/10.1097/MAT.0000000000001188.
Jeng EI, et al. Ventricular assist device implantation and bariatric surgery: a route to transplantation in morbidly obese patients with end-stage heart failure. ASAIO J. 2020;67(2):163–8.
Petty M, Bauman L. Psychosocial issues in ventricular assist device implantation and management. J Thorac Dis. 2015;7(12):2181–7. https://doi.org/10.3978/j.issn.2072-1439.2015.09.10.
Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1–6.
Dunlay SM, et al. Frailty and outcomes after implantation of left ventricular assist device as destination therapy. J Heart Lung Transplant. 2014;33(4):359–65.
Flint KM, et al. Frailty and the selection of patients for destination therapy left ventricular assist device. Circ Heart Fail. 2012;5(2):286–93.
Santa Mina D, Scheede-Bergdahl C, Gillis C, Carli F. Optimization of surgical outcomes with prehabilitation. Appl Physiol Nutr Metab. 2015;40:966–9.
Durrand J, Singh SJ, Danjoux G. Prehabilitation. Clin Med. 2019;19(6):458–64.
Kerrigan DJ, et al. Cardiac rehabilitation improves functional capacity and patient-reported health status in patients with continuous-flow left ventricular assist devices: the rehab-VAD randomized controlled trial. JACC Heart Fail. 2014;2(6):653–9. https://doi.org/10.1016/j.jchf.2014.06.011.
Leon AS, Franklin BA, Costa F, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2005;111:369–76.
Angermann C, et al. Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF). Eur J Heart Fail. 2020;22(10):1891–901.
Veenis J, Brugts JJ. Pre-LVAD hemodynamically optimization by CardioMEMS to improve post-LVAD surgery quality of life & functional performance. J Am Coll Cardiol. 2020;75(11):941.
Slaughter M, Pagani F, Rogers F, Miller L, Sun B, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4S):S1–39.
Kavarana MN, Pessin-Minsley MS, Urtecho J, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg. 2002;73:745–50.
Ochiai Y, McCarthy PM, Smedira NG, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106:I198–202.
Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, et al. The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32(2):157–87.
Harjola V-P, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology: contemporary management of acute RV failure. Eur J Heart Fail. 2016;18(3):226–41.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rhoades, B., Hamm, H., Stewart, S. (2022). Patient Optimization Prior to MCS. In: Stewart, S., Blood, P. (eds) A Guide to Mechanical Circulatory Support. Springer, Cham. https://doi.org/10.1007/978-3-031-05713-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-031-05713-7_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-05712-0
Online ISBN: 978-3-031-05713-7
eBook Packages: MedicineMedicine (R0)